Vogel Conflict Test

Overview

The Vogel conflict test (Vogel et al., 1971) is a punishment-based anxiety paradigm in which water-deprived rodents receive a mild foot shock or lip shock after a set number of licks from a water spout. The conflict between the drive to drink and the aversive consequence of shock produces a suppression of licking that is selectively attenuated by anxiolytic drugs. The test is considered one of the most pharmacologically predictive models of clinical anxiolytic efficacy, with strong sensitivity to benzodiazepines, barbiturates, and serotonergic anxiolytics (Millan & Brocco, 2003).

Primary dependent variables include the number of punished licks (licks completed despite shock delivery), number of shock-free licks in unpunished periods, total number of shocks accepted, and the punishment ratio (punished licks / total licks). Secondary measures include latency to first lick, inter-lick interval patterns, and lick bout structure. Anxiolytic compounds increase the number of punished licks without affecting unpunished licking, distinguishing anti-conflict effects from general motor stimulation.

ConductMaze controls the lickometer circuit, shock delivery through the spout or grid floor, and the punishment schedule (fixed-ratio or variable-ratio). The software counts licks in real time, delivers shock after the programmed number of licks, and computes conflict metrics across configurable punishment schedules. Unpunished pre-test periods establish baseline lick rates for normalization.

Trial Flow

start

Water Deprivation

Animals water-deprived for 24–48 h prior to testing to establish drinking motivation.

input

Unpunished Baseline

3 min access to water spout without shock; baseline lick rate and latency measured.

process

Punishment Phase Onset

Shock contingency activated; shock delivered after every N licks (e.g., FR-20 schedule).

decision

Lick-Shock Monitoring

System counts licks and delivers shock when ratio criterion met; records punished vs. unpunished licks.

process

Conflict Period

Animal continues 3 min punished period; total shocks accepted and lick patterns recorded.

output

Metric Computation

Punished licks, shocks accepted, punishment ratio, and lick bout structure calculated.

end

Session End

Data exported; animal returned to home cage with ad libitum water for 1 h recovery.

Parameters

ParameterTypeDefaultDescription
Deprivation Periodinteger48Water deprivation duration in hours prior to testing.
Shock Intensityfloat0.3Shock intensity in milliamps (mA); adjusted per species (0.1–0.5 mA).
Shock Durationfloat1.0Duration of each shock pulse in seconds.
Punishment Ratiointeger20Fixed-ratio schedule: number of licks between successive shocks.
Unpunished Periodinteger180Duration of shock-free baseline period in seconds.
Punished Periodinteger180Duration of punishment phase in seconds.
Spout Lickometer Sensitivityinteger5Minimum tongue contact duration (ms) to register as a lick.

Metrics

MetricUnitDescription
Unpunished LickscountTotal licks during the shock-free baseline period.
Punished LickscountTotal licks during the punishment phase; primary anxiolytic endpoint.
Shocks AcceptedcountNumber of shock deliveries tolerated during the punishment phase.
Punishment RatioratioPunished licks / (unpunished + punished licks); higher values indicate anxiolytic effect.
Latency to First LicksTime from spout access to first lick, reflecting approach motivation.
Mean Inter-Lick IntervalmsAverage time between consecutive licks; reflects microstructure of drinking.
Lick Bout CountcountNumber of discrete licking bouts (separated by ≥ 2 s pause) during punishment phase.

Sample Data

SubjectGroupUnpunished LicksPunished LicksShocks AcceptedPunishment Ratio

Representative data for illustration purposes. Actual values will vary by species, strain, and experimental conditions.

Applications

  • 1
    Anxiolytic drug screeningbenzodiazepines, barbiturates, and 5-HT1A agonists dose-dependently increase punished licking.
  • 2
    GABA-A receptor pharmacologysubtype-selective modulators (alpha-2/3 selective) tested for anti-conflict efficacy without sedation.
  • 3
    Anxiety disorder modelingvalidating transgenic or stress-induced anxiety phenotypes with pharmacological reversal.
  • 4
    Novel anxiolytic targetsscreening CRF1 antagonists, neurosteroids, and endocannabinoid modulators.
  • 5
    Pain-anxiety interactionevaluating how chronic pain states alter conflict behavior and anxiolytic responsiveness.

Compatible Products

CS-STARTLEME-VF-SET

Ready to Automate Your Behavioral Protocols?

Contact us for a demo and pricing information.